• From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

  • Aug 12 2024
  • Length: 21 mins
  • Podcast

From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

Listen for free

View show details

  • Summary

  • In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).

    The wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including:

    • Why traditional methods of Alzheimer’s testing are expensive, invasive, and limit access.
    • The benefits of blood-based biomarkers for Alzheimer’s diagnosis.
    • How better diagnostics will benefit patients.
    • Why we’re on the cusp of a new golden age of neurology
    • How more biomarkers fuel not only better diagnostics but better treatments.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available